The economic impact of visceral leishmaniasis on households in Bangladesh

Tropical Medicine & International Health : TM & IH
D Anoopa SharmaDeborah A McFarland

Abstract

To explore current patterns of diagnosis and treatment, quantify household economic impact and identify household strategies to cover the costs of visceral leishmaniasis (VL) care in rural Bangladesh. Structured interviews with 113 VL patients from 87 households documenting all provider visits and expenditures for health care for VL, and the ways in which the expenditures were covered. Patients paid a median of 7 visits to six different providers before beginning VL treatment. All visited the subdistrict government hospital at least once. While health care, including antileishmanial drug therapy, is officially available free of charge at government facilities, 79% of patients reported making informal payments for provider access, diagnostics and drug administration; only 14% of patients received their full drug course from this source. For the 58% of patients who purchased the full treatment course, drug cost constituted 34% of direct expenditure. Median direct expenditure for one VL patient was US$87 and median income lost was $40; median total expenditure was 1.2 times annual per capita income of our study population. Households employed multiple coping strategies to cover expenditures, most commonly sale or rental of assets ...Continue Reading

References

Dec 1, 1987·The Journal of Infectious Diseases·B J CerfW D Johnson
Aug 1, 1996·Social Science & Medicine·R SauerbornM Hien
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Berman
Jul 18, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·C P Thakur
Jan 2, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·M BoelaertP Van der Stuyft
Jun 5, 2001·The American Journal of Tropical Medicine and Hygiene·C BernM B Bista
Jun 28, 2003·Tropical Medicine & International Health : TM & IH·Bruno MeessenGerald Bloom
Aug 29, 2003·Acta Tropica·Shiva Raj Adhikari, Nephi Matangi Maskay
Sep 27, 2003·Lancet·Wim Van DammeKatharina Kober
Mar 26, 2004·Tropical Medicine & International Health : TM & IH·Wim Van DammeBruno Meessen
May 14, 2005·Emerging Infectious Diseases·Caryn BernJames H Maguire

❮ Previous
Next ❯

Citations

Sep 4, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·S RijalF Chappuis
Aug 31, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Caryn BernJorge Alvar
Jan 11, 2008·International Journal of Epidemiology·Jan H KolaczinskiSimon Brooker
Oct 30, 2008·PLoS Neglected Tropical Diseases·Caryn BernJorge Alvar
Nov 5, 2010·PLoS Neglected Tropical Diseases·Asrat HailuUNKNOWN Leishmaniasis East Africa Platform (LEAP) group
Sep 15, 2010·PLoS Neglected Tropical Diseases·Filip MeheusMarleen Boelaert
Nov 6, 2013·The American Journal of Tropical Medicine and Hygiene·Filip MeheusAhmed M Musa
Sep 8, 2011·The American Journal of Tropical Medicine and Hygiene·Masayo OzakiCaryn Bern
Jun 16, 2010·Drug Development and Industrial Pharmacy·Sheila J ThorntonEllen K Wasan
Oct 24, 2006·Tropical Medicine & International Health : TM & IH·Filip MeheusShyam Sundar
May 22, 2010·Tropical Medicine & International Health : TM & IH·Rhonda SarnoffPradeep Das
May 22, 2010·Tropical Medicine & International Health : TM & IH·Shyam SundarBeena Varghese
Jul 2, 2010·Tropical Medicine & International Health : TM & IH·F Meheus, M Boelaert
Oct 7, 2006·Trends in Parasitology·Jorge AlvarCaryn Bern
Nov 26, 2010·Annals of Tropical Medicine and Parasitology·M BoelaertP Lutumba
Feb 19, 2013·Social Science & Medicine·Susan ClearyDi McIntyre
Feb 28, 2015·PLoS Neglected Tropical Diseases·Daniel S MarinhoIuri C Leite
Aug 22, 2014·PLoS Neglected Tropical Diseases·Rajib ChowdhuryAditya Prasad Dash
Aug 2, 2012·Memórias do Instituto Oswaldo Cruz·Gouri Sankar BhuniaShreekant Kesari
Dec 5, 2018·Expert Review of Anti-infective Therapy·Temmy SunyotoFilip Meheus
May 9, 2013·Tropical Medicine & International Health : TM & IH·E NazninG Gedik
Sep 28, 2017·Revista Da Sociedade Brasileira De Medicina Tropical·Tália Santana Machado de AssisAna Rabello
Jun 8, 2017·Computational and Mathematical Methods in Medicine·Helio Junji ShimozakoEduardo Massad
Oct 3, 2018·PLoS Neglected Tropical Diseases·Rajib ChowdhuryQamar Banu
Nov 9, 2018·BioMed Research International·Tharaka WijerathnaKithsiri Gunawardena
Jul 1, 2021·Research and Reports in Tropical Medicine·Grace GriffertyRichard Wamai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Transactions of the Royal Society of Tropical Medicine and Hygiene
S RijalM Boelaert
Tropical Medicine & International Health : TM & IH
F MeheusShyam Sundar
Transactions of the Royal Society of Tropical Medicine and Hygiene
C P Thakur
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Koert RitmeijerRobert Davidson
© 2022 Meta ULC. All rights reserved